Innate Pharma SA (IPHA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov6

Innate Pharma SA to Release FY2025 Q3 Earnings on November 13 Pre-Market EST, Forecast Revenue USD 2.324 M, EPS USD -0.142

00:24

Oct28

Innate Pharma SA Outlines Strategy and Pipeline for Next-Generation Antibody Cancer Therapies

12:13

Sep17

Innate Pharma SA released FY2025 Semi-Annual Earnings on September 17 Pre-Market EST, actual revenue USD 5.475 M (forecast USD 12.23 M), actual EPS USD -0.2816 (forecast USD -0.35)

13:30

Innate Pharma SA released FY2025 Q1 earnings on September 17 Pre-Market EST, actual revenue USD 2.63 M, actual EPS USD -0.1353

13:30

Innate Pharma SA released FY2025 Q2 earnings on September 17 Pre-Market (EST), actual revenue USD 2.844 M, actual EPS USD -0.1436

13:30

Sep9

Innate Pharma SA to Release FY2025 Semi-Annual Earnings on September 16, 2025 (EST), Forecast Revenue USD 12.27 M, EPS USD -0.35

00:10

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release

Sep17

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.844 M, Net Income -12.49 M, EPS -0.1463

May13

Earning Release(EST)

FY2025 Q1 Earning Release

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More